Drug
Diprivan
Diprivan is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_4
1
20%
Ph phase_1
1
20%
Ph phase_2
1
20%
Ph early_phase_1
1
20%
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
Trials by Status
completed360%
unknown120%
withdrawn120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Burst Suppression Anesthesia for Treatment of Severe Depression
NCT02935647
withdrawnphase_2
Neural and Antidepressant Effects of Propofol (Phase 2)
NCT03923361
unknownearly_phase_1
Anesthesia Depth's Influence on Postoperative Delirium
NCT02972762
completedphase_3
Therapeutic Equivalence (TE) Study of Propofol 2% MCT Fresenius (MCT=Medium-Chain Triglycerides) Compared With Diprivan® in Patients Undergoing Elective Surgery
NCT01856998
completedphase_4
Population PK/PD of Propofol in the Morbidly Obese Patient
NCT00395681
Clinical Trials (5)
Showing 5 of 5 trials
NCT02935647Phase 1
Burst Suppression Anesthesia for Treatment of Severe Depression
NCT03923361Phase 2
Neural and Antidepressant Effects of Propofol (Phase 2)
NCT02972762Early Phase 1
Anesthesia Depth's Influence on Postoperative Delirium
NCT01856998Phase 3
Therapeutic Equivalence (TE) Study of Propofol 2% MCT Fresenius (MCT=Medium-Chain Triglycerides) Compared With Diprivan® in Patients Undergoing Elective Surgery
NCT00395681Phase 4
Population PK/PD of Propofol in the Morbidly Obese Patient
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5